A Pilot Trial of Curcumin Effects on Cognition in Schizophrenia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This is an 8-week randomized, double-blind, placebo-controlled, parallel, fixed-dose pilot clinical trial of curcumin for the treatment of cognitive impairment in schizophrenia.The primary aim of this pilot trial is to provide an effect size estimate for the efficacy of curcumin in improving cognitive functioning in schizophrenia. Secondary goals are to determine the effect of curcumin over time on negative and positive symptoms, in association with inflammatory markers.
Epistemonikos ID: 89353c4e70d5d3b7eee0e7da7450394226e3c8d8
First added on: May 12, 2024